Finegold, David N.

Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox‐1 homeobox transcription factor

Petrova, T. V., Mäkinen, T., Mäkelä, T. P., Saarela, J., Virtanen, I., Ferrell, R. E., Finegold, D. N., Kerjaschki, D., Ylä‐Herttuala, S., & Alitalo, K. (2002) · The EMBO Journal

Lymphatic System and DiseasesLymphatic Disorders and Treatments

Cited by 632

Photonic Crystal Glucose-Sensing Material for Noninvasive Monitoring of Glucose in Tear Fluid

Alexeev, V. L., Das, S., Finegold, D. N., & Asher, S. A. (2004) · Clinical Chemistry

Photonic Crystals and ApplicationsPolydiacetylene-based materials and applications

Cited by 370

Tear glucose analysis for the noninvasive detection and monitoring of diabetes mellitus

Baca, J. T., Finegold, D. N., & Asher, S. A. (2007) · The Ocular Surface

Ocular Surface and Contact LensDiabetes Management and Research

Cited by 187

Glycemic response to glucagon during fasting hypoglycemia: an aid in the diagnosis of hyperinsulinism

Finegold, D. N., Stanley, C. A., & Baker, L. (1980) · The Journal of Pediatrics

Pancreatic function and diabetesMetabolism and Genetic Disorders

Cited by 150

Mass spectral determination of fasting tear glucose concentrations in nondiabetic volunteers

Baca, J. T., Taormina, C. R., Feingold, E., Finegold, D. N., Grabowski, J. J., & Asher, S. A. (2007) · Clinical Chemistry

Mass Spectrometry Techniques and ApplicationsOcular Surface and Contact Lens

Cited by 110